Anthrax as an example of the One Health concept

OIE Revue Scientifique et Technique

Volumn 33, Issue 2, 2014, Pages 593-604

  Bengis, R G ^a   Frean, J ^b  

^a Centre collaborateur de l'Organisation mondiale de la santé animale   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Anthrax; Environmental persistence; Host susceptibility; One Health; Transmission; Zoonosis

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL VACCINE;

AFRICA; ANIMAL; ANTHRAX; HEALTH; HUMAN; IMMUNOLOGY; INTERNATIONAL COOPERATION; PATHOLOGY; TRANSMISSION; VETERINARY; WILD ANIMAL; ZOONOSES;

AFRICA; ANIMALS; ANIMALS, WILD; ANTHRAX; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; GLOBAL HEALTH; HUMANS; INTERNATIONALITY; ZOONOSES;

EID: 84908145336     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.33.2.2309     Document Type: Review

References (34)

1. Choquette L. P. E. (1970). - Anthrax. In Infectious diseases of wild mammals (J. W Davis, L. H. Karstadt & D. O. Trainer, eds). Iowa State University Press, Ames, Iowa, 256-266.
2. Sterne M. (1959). - Anthrax. In Infectious diseases of animals: diseases due to bacteria (A. W Stableforth & I. A. Galloway, eds). Academic Press, New York, 16-52.
3. Cormack Gates C., Elkin B. & Dragon D. (2001). - Anthrax. In Infectious diseases of wild mammals, 3rd Ed. (E. S. Williams & I. K. Barker, eds). Iowa State University Press, Ames, Iowa, 396-412.
4. Hugh-Jones M. & Blackburn J. (2009). - The ecology of Badllus anthracis. Uolec. Asp. Med., 30(6), 356-367.
5. Koshikawa T., Tamazaki M. & Yoshimi M. (1989). - Surface hydrophobicity of spores of Bacillus spp. J. gen. Microbiol., 135, 2717-2722.
6. Gould G. W. (1984). - Mechanisms of resistance and dormancy. In The bacterial spore (A. Hurst & G. W Gould, eds). Academic Press, Toronto, 173-209.
7. Dragon D. C. & Rennie R. E (1995). - The ecology of anthrax spores: tough but not invincible. Can. vet. J., 36, 295-301.
8. Keim P, Kalif A., Schupp J., Hill K., Travis S. E., Richmond K., Adair D. M., Hugh-Jones M., Kuske C. R. & Jackson P (1997). - Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J. Bacteriol., 179, 818-824.
9. Mullins J. C., Garofolo G., Van Ert M., Fasanella A., Luknova L., Hugh-Jones M. E. & Blackburn J. K. (2013). - Ecological niche modelling of Bacillus anthracis on three continents: evidence for genetic-ecological divergence? PLoS ONE, 8(8), e72451. doi: 10.137 l/Joumal.pone.0072451.
10. Smith K. L., de Vos V, Bryden H., Price L. B., Hugh-Jones M. E. & Keim P. (2000). - Bacillus anthracis diversity in the Kruger National Park. J. clin. Microbiol., 38(10), 3780-3784.
11. De Vos V & Turnbull PC. (2004). - Anthrax. In Infectious diseases of livestock, 2nd Ed. (J. A. W. Coetzer & R. C. Tustin, eds). Oxford University Press, Oxford, 1788-1818.
12. Hugh-Jones M. E. & de Vos V. (2002). - Anthrax and wildlife. In Infectious diseases of wildlife: detection, diagnosis and management (Part Two) (R. G. Bengis, ed.). Rev. sci. tech. Off. int. Epiz, 21(2), 359-383.
13. Coker PR., Smith K. L., Fellows PE, Rybachuck G., Kousoulas K. G. & Hugh-Jones M. E. (2003). - Bacillus anthracis virulence in guinea pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality. J. clin. Microbiol, 41(3), 1212-1218.
14. World Organisation for Animal Health, Food and Agriculture Organization of the United Nations & World Health Organization (WHO) (2008). - Manual on anthrax in humans and animals, 4th Ed. (PC. Turnbull, ed.). WHO, Geneva.
15. Hoover D. L., Friedlander A. M., Rogers L. C., Yoon I. K., Warren R. L. & Cross A. S. (1994). - Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP Infect. Immun., 62(10), 4432-4439.
16. Cromartie WJ., Bloom WL. & Watson D. W (1947). - Studies on infection with Bacillus anthracis. 1. A histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species. J. infect. Dis., 80, 1-13.
17. Ianaco-Connors L. C., Schmaljohn C. S. & Dalrymple J. M. (1990). - Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants. Infect Immun., 58(2), 366-372.
18. Bengis R. G. (2012). - Anthrax in free-ranging wildlife. In Fowler's zoo and wild animal medicine: current therapy, Vol. 7 (R. E. Miller & M. Fowler, eds). Elsevier Saunders Press, St Louis, Missouri, 98-107.
19. Turnbull PC., Carman J. A., Lindeque P. M., Joubert E, Hubschle O. J. B. & Snoeyenbos G. H. (1989). - Further progress in understanding anthrax in Etosha National Park. Madoqua, 16(2), 93-104.
20. Lindeque EM. & Turnbull PC. B. (1994). - Ecology and epidemiology of anthrax in Etosha National Park, Namibia. OnderstepoortJ. vet. Res., 61, 71-83.
21. Kriek N. PJ. & de Vos V. (1996). - Species differences in the pathology of wildlife in the Kruger National Park, South Africa. Salisbury med. Bull. (Suppl.), 87, 82.
22. Smith H. A. & Jones T. C. (1966). - Diseases due to simple bacteria (anthrax). In Veterinary pathology, 3rd Ed. Lea and Febiger, Philadelphia, 463-466.
23. De Vos V & Bryden H. B. (1996). - Anthrax in the Kruger National Park: temporal and spatial patterns of disease occurrence. Salisbury med. Bull. (Suppl.), 87, 26-30.
24. Ebedes H. (1976). - Anthrax epizootics in Etosha National Park. Madoqua, 10, 99-118.
25. Turnbull PC. (1992). - Serology and anthrax in humans, livestock and Etosha National Park wildlife. Epidemiol. Infect., 108, 299-313.
26. Fasanella A., Garofolo G., Galella M., Troiano P., De Stefano C., Pace L., Aceti A., Serrecchia L. & Adone R. (2013). - Suspect vector transmission of human cutaneous anthrax during an animal outbreak in Southern Italy. Vector-borne Zoonotic Dis., 13(10), 769-771.
27. Powell A. G., Crozier J. E., Hodgson H. & Galloway D. J. (2011). - A case of septicaemic anthrax in an intravenous drug user. BMC infect. Dis., 11, 21.
28. Beatty M. E., Ashford D. A., Griffin P. M., Tauxe R. V & Sobel J. (2003). - Gastrointestinal anthrax: review of the literature. Arch, internal Med., 163(20), 2527-2531.
29. Ross J. M. (1957). - The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol, 73, 485-494.
30. Inglesby T. V, O'Toole T., Henderson DA., Bartlett J. G., Ascher M. S., Eitzen E., Friedlander A. M., Gerberding J., Hauer J., Hughes J., McDade J., Osterholm M. T., Parker G., Perl T. M., Russell PK., Tonat K.; Working Group on Civilian Biodefense (2002). - Anthrax as a biological weapon. In Bioterrorism: guidelines for medical and public health management (D. A. Henderson, T. V Inglesby & T. OToole, eds). AMA Press, Chicago, 63-97.
31. Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokov A. & Yampolskaya O. (1994). - The Sverdlovsk anthrax outbreak of 1979. Science, 266, 1202-1208.
32. World Organisation for Animal Health (OIE) (2013). - Terrestrial Animal Health Code, 22nd Ed. OIE, Paris. Available at: www.oie.int/en/intemational-standard-setting/terrestrialcode/access-online/ (accessed on 10 June 2014).
33. Sterne M. (1939). - The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J. vet. Sci., 13, 307-312.
34. Jackson EC., Wight G. G. & Armstrong J. (1957). - Immunization of cattle against experimental anthrax, with alum-precipitated protective antigen or spore vaccine. Am. J. vet. Res., 18, 771-777.